Form 4 holding
Chief Executive Officer, Director
Medline Inc.
- Security class
- Class A Common Stock
- Shares / value
- 29,369
- Estimated value
- $1,306,920
- Report date
- 15 Jun 2026
- Price
- $44.50
- Ownership
- Direct
James M. Boyle
Insider Reports History
- Reporting-owner location
- Northfield, IL
- Latest reporting-owner signature
-
/s/ Nicole Fritz, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for James M. Boyle
Form 4 holding
Chief Executive Officer, Director
Medline Inc.
- Security class
- Incentive Units of Medline Holdings, LP
- Shares / value
- 1,057,309
- Estimated value
- Report date
- 16 Dec 2025
- Price
- Ownership
- Indirect
- Underlying class
- Class A Common Stock
- Underlying amount
Form 4 holding
Chief Executive Officer, Director
Medline Inc.
- Security class
- Class B Common Stock
- Shares / value
- 514,876
- Estimated value
- Report date
- 17 Dec 2025
- Price
- Ownership
- Indirect
Form 4 holding
Chief Executive Officer, Director
Medline Inc.
- Security class
- Common Units of Medline Holdings, LP
- Shares / value
- 514,876
- Estimated value
- Report date
- 16 Dec 2025
- Price
- Ownership
- Indirect
- Underlying class
- Class A Common Stock
- Underlying amount
Form 4 holding
Chief Executive Officer, Director
Medline Inc.
- Security class
- Class B Common Stock
- Shares / value
- 24,313
- Estimated value
- Report date
- 17 Dec 2025
- Price
- Ownership
- Direct
Insider Reports Filed by James M. Boyle
4
MDLN
Medline Inc.
- Report period
- 15 Jun 2026
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 17 Jun 2026, 16:44
- Role
- Chief Executive Officer, Director
- Next action
- Open filing details
3
MDLN
Medline Inc.
- Report period
- 17 Dec 2025
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 17 Dec 2025, 19:05
- Role
- Chief Executive Officer, Director
- Next action
- Open filing details
4
MDLN
Medline Inc.
- Report period
- 16 Dec 2025
- Transactions
- 11
- Transaction value
- $0
- Accepted by SEC
- 06 Mar 2026, 16:30
- Role
- Chief Executive Officer, Director
- Next action
- Open filing details